We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Provectus Biopharmaceuticals Inc (QB) | USOTC:PVCT | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.0036 | -1.85% | 0.1913 | 0.1913 | 0.198 | 0.197965 | 0.1913 | 0.195 | 169,171 | 21:00:02 |
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the Securities
Exchange Act of 1934
Filed by the registrant ☐ Filed by a party other than the registrant ☒
Check the appropriate box:
☐ | Preliminary proxy statement | |
☐ | Confidential, for use of the Commission only (as permitted by Rule 14a-6(e)(2)) | |
☐ | Definitive proxy statement | |
☐ | Definitive additional materials | |
☒ | Soliciting material pursuant to §240.14a-12 |
Provectus Biopharmaceuticals, Inc.
(Name of Registrant as Specified In Its Charter)
Peter R. Culpepper
(Name of Person Filing Proxy Statement)
Payment of filing fee (Check the appropriate box):
April 19, 2017
Dr. Timothy Scott
President
Provectus Biopharmaceuticals, Inc.
7327 Oak Ridge Highway
Knoxville, TN 37931
Dear Dr. Scott:
This is to inform you that I will not be nominating persons for election at the 2017 annual meeting of stockholders of Provectus Biopharmaceuticals, Inc., to serve as directors of Provectus.
Sincerely,
/s/ Peter R. Culpepper
Peter R. Culpepper
2
1 Year Provectus Biopharmaceuti... (QB) Chart |
1 Month Provectus Biopharmaceuti... (QB) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions